MusclePharm Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 16, 2021 at 04:05 pm EDT
MusclePharm Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 14.908 million compared to USD 16.993 million a year ago. Operating loss was USD 1.743 million compared to operating Income of USD 350,000 a year ago. Net loss was USD 2.251 million compared to USD 253,000 a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.01 a year ago. For the half year, sales was USD 28.029 million compared to USD 33.224 million a year ago. Operating loss was USD 1.470 million compared to operating Income of USD 901,000 a year ago. Net loss was USD 2.157 million compared to USD 313,000 a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.01 a year ago.